Clinical impact of CYP2C19 polymorphism on the action of proton pump inhibitors: a review of a special problem
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- March 1, 2007
has subject area
- 1115 Pharmacology and Pharmaceutical Sciences (FoR)
- Anti-Ulcer Agents (MeSH)
- Aryl Hydrocarbon Hydroxylases (MeSH)
- Cytochrome P-450 CYP2C19 (MeSH)
- Helicobacter pylori (MeSH)
- Mixed Function Oxygenases (MeSH)
- Pharmacology & Pharmacy (Science Metrix)
- Polymorphism, Genetic (MeSH)
- Proton Pump Inhibitors (MeSH)